Board meeting set for 6 November to approve quarterly results

Results View source PDF Explain this filing

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹463.45

prior close

₹463.00

announcement price

After-mkt

timing

Nifty Smallcap 250marketpendingvs market: pending

Pharmaceuticals peers, median of 173sector+2.0%+1.9% vs sector

On the reaction day the stock moved 1.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.1

15m

+0.2

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.8pendingpending+2.0+1.9

Next day

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board will meet on 6 November 2026 to approve unaudited standalone and consolidated financial results for the quarter and half-year ended 30 September 2026. The trading window for designated persons and their immediate relatives remains closed until 9 November 2026.

Likely market impact

No earnings figures have been disclosed, so the stock's near-term direction remains uncertain. Insider trading remains restricted until 9 November.